Blood Pressure Control and Pharmacotherapy Patterns in the United States Before and After the Release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Guidelines

被引:34
作者
Jackson, James H. [1 ]
Sobolski, John [2 ]
Krienke, Russ [3 ]
Wong, Ken S. [4 ]
Frech-Tamas, Feride [4 ]
Nightengale, Brian [1 ]
机构
[1] Xcenda, Palm Harbor, FL 34685 USA
[2] Advocate Hlth Care, Cardiol Sect, Chicago, IL USA
[3] Austin Reg Clin, Austin, TX USA
[4] Novartis Pharmaceut, Dept Evidence Based Med, E Hanover, NJ USA
关键词
D O I
10.3122/jabfm.2008.06.080025
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: Despite recommendations from the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7), only 36.8% of patients were at target blood pressure (BP) in 2003 and 2004. The objective of this study was to assess improvements in BP control and treatment patterns before and after the publication of JNC 7. Methods: This was a retrospective, time series analysis of 27 provider groups and managed care organizations from 1998 through 2006. Patients with hypertension were identified from more than 4000 physicians. Medical charts were collected and clinical data were evaluated using prevailing JNC criteria during the time period before and after JNC 7. Results: A total of 19,258 patients were identified with hypertension: 15,258 included in the before-JNC 7 cohort and 4,000 in the after-JNC 7 cohort. BP control in the before-JNC 7 cohort was 40.8% compared with 49.3% in the after-JNC 7 cohort (P < .0001). After controlling for demographic and clinical covariates, patients in the before-JNC 7 cohort were 45% less likely to achieve BP control compared with the after-JNC 7 cohort (odds ratio, 0.551; P < .0001). Conclusion: Although findings indicate BP control is improving, a significant need for further improvement remains. (J Am Board Fam Med 2008; 21: 512-21.)
引用
收藏
页码:512 / 521
页数:10
相关论文
共 14 条
  • [1] *AM HEART ASS, 2008, HEART DIS STROK STAT, P18
  • [2] Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes
    Andros, Vickie
    Egger, Allison
    Dua, Uma
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2006, 12 (04): : 303 - 309
  • [3] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
  • [4] The treatment of hypertension in adult patients with diabetes
    Arauz-Pacheco, C
    Parrott, MA
    Raskin, P
    [J]. DIABETES CARE, 2002, 25 (01) : 134 - 147
  • [5] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [6] Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393
  • [7] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    [J]. LANCET, 2002, 359 (9311) : 995 - 1003
  • [8] Elevated blood pressure among US adults with diabetes, 1988-1994
    Geiss, LS
    Rolka, DB
    Engelgau, MM
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2002, 22 (01) : 42 - 48
  • [9] Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis
    Iskedjian, M
    Einarson, TR
    MacKeigan, LD
    Shear, N
    Addis, A
    Mittmann, N
    Ilersich, AL
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (02) : 302 - 316
  • [10] Maue Susan K, 2003, J Clin Hypertens (Greenwich), V5, P33, DOI 10.1111/j.1524-6175.2003.02466.x